This series will provide clinicians with an early practical interpretation of the most-current, as well as emerging updates in cardiovascular-kidney-metabolic (CKM) care. Evolving approaches to risk recognition, interdisciplinary management, and implementation of evidence-based therapies across the CKM continuum will be addressed. The series is designed to help clinicians prepare for anticipated shifts in guideline-directed care while translating evolving recommendations into real-world practice.